홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Heptane → 3-[2-[Tert-butyl(dimethyl)silyl]oxyethyl]-2-[2-(4-isopropylsulfonylphenyl)-5-trityl-pyrrolo[2,3-b]pyrazin-7-yl]isoindolin-1-one

HRID 627801
인쇄

반응식

HRID 627801 반응식
[CH:1]([S:4]([C:7]1[CH:12]=[CH:11][C:10]([C:13]2[N:14]=[C:15]3[C:21]([NH2:22])=[CH:20][N:19]([C:23]([C:36]4[CH:41]=[CH:40][CH:39]=[CH:38][CH:37]=4)([C:30]4[CH:35]=[CH:34][CH:33]=[CH:32][CH:31]=4)[C:24]4[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=4)[C:16]3=[N:17][CH:18]=2)=[CH:9][CH:8]=1)(=[O:6])=[O:5])([CH3:3])[CH3:2].C[Al](C)C.CCCCCCC.[Si:53]([O:60][CH2:61][CH2:62][CH:63]1[C:71]2[C:66](=[CH:67][CH:68]=[CH:69][CH:70]=2)[C:65](=O)[O:64]1)([C:56]([CH3:59])([CH3:58])[CH3:57])([CH3:55])[CH3:54].C1C=CC(P(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1.CCOC(/N=N/C(OCC)=O)=O>C1(C)C=CC=CC=1.C(Cl)Cl.O>[Si:53]([O:60][CH2:61][CH2:62][CH:63]1[C:71]2[C:66](=[CH:67][CH:68]=[CH:69][CH:70]=2)[C:65](=[O:64])[N:22]1[C:21]1[C:15]2[C:16](=[N:17][CH:18]=[C:13]([C:10]3[CH:9]=[CH:8][C:7]([S:4]([CH:1]([CH3:3])[CH3:2])(=[O:6])=[O:5])=[CH:12][CH:11]=3)[N:14]=2)[N:19]([C:23]([C:36]2[CH:41]=[CH:40][CH:39]=[CH:38][CH:37]=2)([C:30]2[CH:31]=[CH:32][CH:33]=[CH:34][CH:35]=2)[C:24]2[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=2)[CH:20]=1)([C:56]([CH3:59])([CH3:58])[CH3:57])([CH3:55])[CH3:54]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

10

반응물 6

HCID 8900HeptaneHCID 11776TriphenylphosphineHCID 5462977Diethyl azodicarboxylateHCID 16682925TrimethylaluminumHCID 711435912-(4-Isopropylsulfonylphenyl)-5-trityl-pyrrolo[2,3-b]pyrazin-7-amineHCID 711436383-(2-((tert-butyldimethylsilyl)oxy)ethyl)isobenzofuran-1(3H)-one

생성물 1

HCID 711436503-[2-[Tert-butyl(dimethyl)silyl]oxyethyl]-2-[2-(4-isopropylsulfonylphenyl)-5-trityl-pyrrolo[2,3-b]pyrazin-7-yl]isoindolin-1-one수율 66%

시약·촉매·용매 3

HCID 962Water용매HCID 1140Toluene용매HCID 6344Dichloromethane용매2회

실험 절차

2-(4-isopropylsulfonylphenyl)-5-trityl-pyrrolo[2,3-b]pyrazin-7-amine (125 mg, 0.2237 mmol) dissolved in PhMe (3 mL) under N2. AlMe3 in heptane (671.1 μL of 1.0 M, 0.6711 mmol) added at RT and the mixture stirred for 30 mins. A solution of 3-[2-[tert-butyl(dimethyl)silyl]oxyethyl]-3H-isobenzofuran-1-one (130.8 mg, 0.4474 mmol) in DCM (3 mL) added with cooling on an ice bath and the mixture stirred overnight. Reaction mixture re-cooled and water added slowly followed by DCM. After stirring for 30 mins, mixture passed through a phase separator cartridge and filtrate concentrated. Residue taken up in THF (5 mL) and PPh3 (88.02 mg, 0.3356 mmol) then DEAD (42.26 μL, 0.2684 mmol) added at RT under N2. Reaction mixture stirred overnight, then concentrated without heating. Residue partitioned between DCM and brine. Aqueous phase extracted with DCM and combined organics dried and concentrated. Residue taken up in DCM and purified by chromatography (silica, 0-100% EtOAc-petrol gradient elution) to give the title compound as a yellow foam (123 mg, 66% over 2 steps); MS (ES+) 833.3.

후처리

  1. temperaturewith cooling on an ice bath
  2. stirringthe mixture stirred overnight
  3. customReaction mixture
  4. temperaturere-cooled
  5. stirringAfter stirring for 30 mins
  6. concentrationconcentrated
  7. customReaction mixture
  8. stirringstirred overnight
  9. concentrationconcentrated
  10. temperaturewithout heating
  11. customResidue partitioned between DCM and brine
  12. extractionAqueous phase extracted with DCM
  13. customcombined organics dried
  14. concentrationconcentrated
  15. custompurified by chromatography (silica, 0-100% EtOAc-petrol gradient elution)

출처 및 근거

ORD 기록
ord-6c303eb82da14cdab8b81ffb00d8537c
출처 데이터셋
uspto-grants-2016_04
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09309250B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트